Skip to main content
# Title Research Member Research Year
81 Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute
Dr. Azaa Shibl Sayed Mahmoud 2018
82 Risk-Adapted, Combined-Modality Therapy for
Unfavorable Pediatric Hodgkin Lymphom
Prof. Amany Mohamed Ali Ahmed 2018
83 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Dr. Samar Muhammad mansour 2018
84 Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute
Prof. Heba Abdel-Razik Sayed Hussein 2018
85 Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources Prof. Heba Abdel-Razik Sayed Hussein 2018
86 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Dr. Shaimaa / Elsayyed Youssef / Ahmed 2018
87 Bloodstream Infections in Febrile Neutropenic
Pediatric Cancer Patients: Microbiological and
Sepsis Biomarkers Insight
Dr. Khaled Fathy Riad Osman 2018
88 Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources Mahmoud Motaz Elzembely 2018
89 Clinicopathological pattern and outcome of pediatric malignant ovarian germ cell tumors: South Egypt Cancer Institute experience Prof. Amany Mohamed Ali Ahmed 2017
90 Environmentally-Mediated Epigenetic Effects: Uncovering the Fertile Soil in the Development of Pediatric Cancer Dr. Ahmed Mohammed Morsy Hassan 2017